Profile picture

Doctor Ana Marta Castro Pinto

Hospital Guimaraes, Guimaraes (Portugal)
Membership: HFA Member
Follow
Logo ESC

Contributor content

Long-term prognostic value of left ventricular echocardiographic parameters for atrial fibrillation recurrence following pulmonary vein isolation
Presentation
Long-term prognostic value of left ventricular echocardiographic parameters for atrial fibrillation recurrence following pulmonary vein isolation
Impact of LVEF and de novo heart failure on outcomes of SGLT2 inhibitor therapy initiated during acute heart failure
Presentation
Impact of LVEF and de novo heart failure on outcomes of SGLT2 inhibitor therapy initiated during acute heart failure
Diagnostic performance of pre-procedural left atrial size and strain in predicting long-term atrial fibrillation recurrence after pulmonary vein isolation
Presentation
Diagnostic performance of pre-procedural left atrial size and strain in predicting long-term atrial fibrillation recurrence after pulmonary vein isolation
Impact of symptomatic status on atrial fibrillation recurrence after pulmonary vein isolation
Presentation
Impact of symptomatic status on atrial fibrillation recurrence after pulmonary vein isolation
Hypertrophic cardiomyopathy and fabry disease: right ventricular to pulmonary artery coupling can differentiate both?
Presentation
Hypertrophic cardiomyopathy and fabry disease: right ventricular to pulmonary artery coupling can differentiate both?
Impact of sodium-glucose cotransporter-2 inhibitors on recurrence after atrial fibrillation ablation in patients with indications for SGLT2i therapy
Presentation
Impact of sodium-glucose cotransporter-2 inhibitors on recurrence after atrial fibrillation ablation in patients with indications for SGLT2i therapy
Right ventricular-pulmonary artery coupling: a functional approach to distinguishing fabry disease from wild-type transthyretin cardiac amyloidosis
Presentation
Right ventricular-pulmonary artery coupling: a functional approach to distinguishing fabry disease from wild-type transthyretin cardiac amyloidosis

ESC 365 is supported by